TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: contrast dose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Volume of the synchondrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-minute timed run
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite machine strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive improvement in MoCA
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Return of lower-extremity motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new macroalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of remission to sustained normoalbuminuria or microalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGM-derived mean glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perception of cereal as 'Not good to buy for children'
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUCτ,ss for tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax,ss for tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal dimensional changes of the alveolar socket
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical remission at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative lower respiratory symptom score day 0-14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 15-year mortality
Endpoint domain: Mortality/survival
Primary endpoint: development of CV events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Negative cocaine urinalysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous abstinence for three or more weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment retention duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive polygenic association between serum IgG and ALS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Parents' feelings of support and empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Enactment of positive lifestyle changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Classification accuracy of DenseNet121 model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection accuracy of faster R‐CNN model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remaining heartbeats at the end of the observation period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum metabolites related to polyphenols and methylxanthine intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ejection volume (EV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lower-limb functional coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complex attention and executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in olfactory scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of anosmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Continuation rate of pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: effective rate of tumor volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HRQOL (Atrial Fibrillation Effect on Quality of Life score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in the proportion of cardioversions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sPGA 0/1 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: parent-rate autistic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-operative UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of stent colonization
Endpoint domain: Adverse events/effects
Primary endpoint: mean pre-/post-case STAI-6 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-week culture conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-month culture conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in symptoms of NP as measured by SNOT-22
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of responders to SNOT-22
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in annualized AER
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in maximum keratometry (Kmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident HF
Endpoint domain: Mortality/survival
Primary endpoint: Surgical planning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diagnostic accuracy for malformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year cancer-specific mortality (CSM)
Endpoint domain: Mortality/survival
Primary endpoint: 5-year overall cancer mortality (OCM)
Endpoint domain: Mortality/survival
Primary endpoint: Global cognition z score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attention/information z score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Memory z score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NCB adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: fatigue catastrophizing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in gingival bleeding sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep onset and sleep maintenance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reduction in diurnal IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: total quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PaO2 /FiO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: NSE levels in active disease phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: S100B plasma levels at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sensitivity for detection of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity for identification of patients with severe coronary artery disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Inter-reader agreement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall sedation requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO/ISUP grade prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction of LH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction of testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma FGF21 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: TBR<54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement precision of DEQ-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal consistency reliability of DEQ-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy in screening for dry eye signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: implicit age bias
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reversible chemosis
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal sensitivity decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NPO scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: risk of stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of sleep disorder
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: mean number of active joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MOPS (Modified Objective Pain Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 physical health domain scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bone marrow edema extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of HNC
Endpoint domain: Mortality/survival
Primary endpoint: Deaths from HNC
Endpoint domain: Mortality/survival
Primary endpoint: Mean NRS for nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in PANSS-T scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in global functionality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean urinary sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: All-cause death or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: New-onset ESRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Need for new RRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: spatial learning and memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major adverse cardiovascular event (MACE)-1
Endpoint domain: Mortality/survival
Primary endpoint: Major adverse cardiovascular event (MACE)-2
Endpoint domain: Mortality/survival
Primary endpoint: Recall of alcohol responsibility messages
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attention to alcohol responsibility messages
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: augmentation index at a heart rate of 75 beats/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Performance via video evaluation for OSATS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GRS performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GRS final product
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional status (PG-SGA score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menopause Rating Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Image perception scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target Vessel Myocardial Infarction (TV-MI)
Endpoint domain: Adverse events/effects
Primary endpoint: Willingness to uptake CBHI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical domain of quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psychological domain of quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average 2-week per person cost of treating venous leg ulcer
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Point prevalence of venous leg ulcer
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Annual cost of treating venous leg ulcer
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Identification of objective responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of RAM cannula to SBP in providing CPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: colorectal cancer-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients reaching therapeutic goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial disease-free survival (IPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence rate of memory decline
Endpoint domain: Adverse events/effects
Primary endpoint: angina-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: nonprocedural myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean iohexol-based GFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean urinary albumin excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Participant anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correct understanding of notifications
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of abnormal test results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delayed recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Simple physical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGA scores indicating disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the model for meniscus tear identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the model for meniscus tear identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the model for meniscus tear identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: parent-child dysfunctional interactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Prediction of lymph node malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy and safety of suburethral adjustment-controlled tape
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Chemotherapy-induced nausea and vomiting prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in BDI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in SF-36 role limitations due to emotional problems
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Habit strength maintenance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Behaviour change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Positive Predictive Value (PPV) of RIPASA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Predictive Value (NPV) of RIPASA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSST performance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skill score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSPE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of IL17-expressing CD4+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gene expression of IL-17
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gene expression of IL-23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain score for intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported body satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: drive for thinness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: approach-avoidance tendencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete the Serial Reaction Time Task (SRTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faster peg and ball performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy on the Rapid Visual Information Processing (RVIP) task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient adherence to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of postoperative thrombotic events
Endpoint domain: Adverse events/effects
Primary endpoint: Resident performance on OSCE encounter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted area under the curve (AUC) change in systolic blood pressure (SBP) from time of treatment to 6 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effect on lesions of CSU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: construct validity of the SSL tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: relationship between SSL and migrants' acculturative stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Displacement between the first cuneiform and second metatarsal base
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of developing heightened depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vascular events
Endpoint domain: Mortality/survival
Primary endpoint: Identification of Lymph Node Metastasis (LNM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indoor Ae. aegypti abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Female Ae. aegypti positive for arboviruses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of grades 2-4 diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: RFD improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQoL improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: comparable rates of survival, thrombotic and bleeding events
Endpoint domain: Mortality/survival
Primary endpoint: KCCQ clinical summary score (CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained changes in medication management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved resident quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: myocardial infarction and CHD death
Endpoint domain: Mortality/survival
Primary endpoint: Area under the concentration-time curve (AUC) for IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean global scar score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perseverative Errors in Wisconsin Card Sorting Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ratio score of Trail Making Test‐Part B to TMT‐Part A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: TEG R time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: TEG maximum amplitude (MA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: TEG coagulation index (CI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: MELD-Na score progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes